DC Field | Value | Language |
dc.contributor.author | Didencu, Alexandru | - |
dc.date.accessioned | 2020-08-18T12:25:25Z | - |
dc.date.available | 2020-08-18T12:25:25Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | DIDENCU, Alexandru. Prospects of cell therapy in the treatment of recurrent and chronic rhinosinusitis in children. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 100-101. | en_US |
dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/11417 | - |
dc.description | Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova | en_US |
dc.description.abstract | Introduction. Chronic rhinosinusitis is an important public health issue, the incidence and
prevalence of which has been constantly growing in both the developing and the developed
countries, having a negative impact on the quality of life and bringing about significant costs for
the diagnosis and treatment. The management of recurrent ting and chronic rhinosinusitis
represents a major concern for the otorhinolaryngology service. Traditionally, the treatment of
recurrent and chronic rhinosinusitis has been performed by administering antibiotics, nasal
irrigation with saline solution, decongestant nasal sprays, topical and systemic corticosteroids,
antihistamines, antileukotrienes, and surgery as needed. Unfortunately, these methods are not
free of risks and adverse effects. At the same time, the efficiency of standard treatment is lower
than expected. | en_US |
dc.language.iso | en | en_US |
dc.publisher | MedEspera | en_US |
dc.subject | recurrent and chronic rhinosinusitis | en_US |
dc.subject | cell therapy | en_US |
dc.subject | immunologic marker | en_US |
dc.title | Prospects of cell therapy in the treatment of recurrent and chronic rhinosinusitis in children | en_US |
dc.type | Article | en_US |
Appears in Collections: | MedEspera 2018
|